PathAI and MedStar Health Partner to Deploy Digital Pathology Platform
The multi-year collaboration includes the deployment of the AISight Dx platform and AI algorithms across the health system’s laboratory network.
The multi-year collaboration includes the deployment of the AISight Dx platform and AI algorithms across the health system’s laboratory network.
A University of Warwick study finds AI cancer detection models may rely on statistical correlations rather than true biomarker signals, raising concerns about reliability in clinical pathology applications.
AI models used to analyze pathology samples can infer patient demographic information, leading to biased cancer diagnoses.
The acquisition adds analytical characterization and molecular design software capabilities to Revvity Signals' platform.
Stellaris is designed to significantly improve how scientists are able to capture three-dimensional images of living cells and tissues.
Integration with Epic Beaker is designed to give lab staff and clinicians faster access to slides and case data through a cloud-based platform, according to the company.